Allergy Therapeutics (AGY) Stock Chart & Stock Price History GBX 7.25 +0.65 (+9.85%) As of 06/13/2025 11:52 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Allergy Therapeutics Stock Price Performance The Allergy Therapeutics (AGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 40.10%, with a year-to-date return of 11.11%. In the past month, the stock has increased 3.57%, reflecting recent market activity. As of the latest close, Allergy Therapeutics traded at GBX 7.25 with a market cap of £356.34 million and volume of 99,844 shares. Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.68%1 Month Performance+3.57%3 Month Performance+3.57%Year-To-Date Performance+11.11%1 Year Performance+40.10% AGY Stock Chart for Saturday, June, 14, 2025 AGY Chart by TradingView Allergy Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025GBX 6.60GBX 7.25+9.85%GBX 7.28GBX 7.2599,844 shs£356.34 million06/12/2025GBX 7.15GBX 6.60-7.69%GBX 7.50GBX 6.60147,784 shs£324.39 million06/11/2025GBX 7GBX 7.15+2.14%GBX 7.50GBX 6.62183,645 shs£351.43 million06/10/2025GBX 7.30GBX 7-4.11%GBX 7.30GBX 6.9929,120 shs£344.06 million06/09/2025GBX 6.80GBX 7.30+7.35%GBX 7.50GBX 6.6072,012 shs£358.80 million06/06/2025GBX 7.40GBX 6.80-8.11%GBX 7.45GBX 6.5840,798 shs£334.23 million06/05/2025GBX 6.80GBX 7.40+8.82%GBX 7.50GBX 6.57136,291 shs£363.72 million06/04/2025GBX 6.90GBX 6.80-1.45%GBX 7.50GBX 6.50197,082 shs£334.23 million06/03/2025GBX 6.80GBX 6.90+1.47%GBX 7.45GBX 6.5056,364 shs£339.14 million06/02/2025GBX 7.10GBX 6.80-4.23%GBX 7.25GBX 6.57420,675 shs£334.23 million Get the Latest News and Ratings for AGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025GBX 6.90GBX 7.10+2.90%GBX 7.19GBX 6.79362,549 shs£348.97 million05/29/2025GBX 7.50GBX 6.90-8.00%GBX 7.50GBX 6.56511,409 shs£339.14 million05/28/2025GBX 7.10GBX 7.50+5.63%GBX 7.60GBX 6.71869,644 shs£368.63 million05/27/2025GBX 7.50GBX 7.10-5.33%GBX 7.50GBX 6.88387,794 shs£348.97 million05/26/2025GBX 7.50GBX 7.50GBX 7.85GBX 7.08251,265 shs£368.63 million05/23/2025GBX 7.15GBX 7.50+4.90%GBX 7.85GBX 7.08251,265 shs£368.63 million05/22/2025GBX 7GBX 7.15+2.14%GBX 7.20GBX 6.71256,802 shs£351.43 million05/21/2025GBX 7.20GBX 7-2.78%GBX 7.20GBX 6.65121,226 shs£344.06 million05/20/2025GBX 7.10GBX 7.20+1.41%GBX 7.50GBX 6.5089,583 shs£353.89 million05/19/2025GBX 7.50GBX 7.10-5.33%GBX 7.50GBX 6.91399,222 shs£348.97 million05/16/2025GBX 7.25GBX 7.50+3.45%GBX 7.50GBX 6.84220,834 shs£368.63 million05/15/2025GBX 7GBX 7.25+3.57%GBX 7.50GBX 6.83189,566 shs£356.34 million05/14/2025GBX 6.90GBX 7+1.45%GBX 7.25GBX 6.99204,686 shs£344.06 million05/13/2025GBX 7.10GBX 6.90-2.82%GBX 7.13GBX 6.60566,316 shs£339.14 million Related Companies APH Stock Chart ANCR Stock Chart VLG Stock Chart EAH Stock Chart STX Stock Chart PXS Stock Chart RGT Stock Chart CEL Stock Chart N4P Stock Chart HELD Stock Chart Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AGY) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGY Stock Free AGY Stock Alerts